A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CDMO Services. This report contains market size and forecasts of Pharmaceutical CDMO Services in global, including the following market information:
Global Pharmaceutical CDMO Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pharmaceutical CDMO Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Drug Substance Development and Manufacturing Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical CDMO Services include Recipharm AB, AMRI Global, Patheon N.V., Aenova Group, Catalent, Inc., Amatsigroup, WuXi AppTec Group, Strides Pharma Science Limited and Piramal Pharma Solutions, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharmaceutical CDMO Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical CDMO Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, by Type, 2022 (%)
Drug Substance Development and Manufacturing
Specialized Services
Lab-based Services
Global Pharmaceutical CDMO Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, by Application, 2022 (%)
Innovative Medicine
Patented Drug
Patent Expired Drug
Global Pharmaceutical CDMO Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical CDMO Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pharmaceutical CDMO Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Recipharm AB
AMRI Global
Patheon N.V.
Aenova Group
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
Strides Pharma Science Limited
Piramal Pharma Solutions
Siegfried Ltd
Fareva Group
FAMAR Health Care Services
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical CDMO Services, market overview.
Chapter 2: Global Pharmaceutical CDMO Services market size in revenue.
Chapter 3: Detailed analysis of Pharmaceutical CDMO Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical CDMO Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pharmaceutical CDMO Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical CDMO Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical CDMO Services Overall Market Size
2.1 Global Pharmaceutical CDMO Services Market Size: 2022 VS 2029
2.2 Global Pharmaceutical CDMO Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmaceutical CDMO Services Players in Global Market
3.2 Top Global Pharmaceutical CDMO Services Companies Ranked by Revenue
3.3 Global Pharmaceutical CDMO Services Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutical CDMO Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pharmaceutical CDMO Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical CDMO Services Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutical CDMO Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical CDMO Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharmaceutical CDMO Services Market Size Markets, 2022 & 2029
4.1.2 Drug Substance Development and Manufacturing
4.1.3 Specialized Services
4.1.4 Lab-based Services
4.2 By Type - Global Pharmaceutical CDMO Services Revenue & Forecasts
4.2.1 By Type - Global Pharmaceutical CDMO Services Revenue, 2018-2023
4.2.2 By Type - Global Pharmaceutical CDMO Services Revenue, 2024-2029
4.2.3 By Type - Global Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmaceutical CDMO Services Market Size, 2022 & 2029
5.1.2 Innovative Medicine
5.1.3 Patented Drug
5.1.4 Patent Expired Drug
5.2 By Application - Global Pharmaceutical CDMO Services Revenue & Forecasts
5.2.1 By Application - Global Pharmaceutical CDMO Services Revenue, 2018-2023
5.2.2 By Application - Global Pharmaceutical CDMO Services Revenue, 2024-2029
5.2.3 By Application - Global Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pharmaceutical CDMO Services Market Size, 2022 & 2029
6.2 By Region - Global Pharmaceutical CDMO Services Revenue & Forecasts
6.2.1 By Region - Global Pharmaceutical CDMO Services Revenue, 2018-2023
6.2.2 By Region - Global Pharmaceutical CDMO Services Revenue, 2024-2029
6.2.3 By Region - Global Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pharmaceutical CDMO Services Revenue, 2018-2029
6.3.2 US Pharmaceutical CDMO Services Market Size, 2018-2029
6.3.3 Canada Pharmaceutical CDMO Services Market Size, 2018-2029
6.3.4 Mexico Pharmaceutical CDMO Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pharmaceutical CDMO Services Revenue, 2018-2029
6.4.2 Germany Pharmaceutical CDMO Services Market Size, 2018-2029
6.4.3 France Pharmaceutical CDMO Services Market Size, 2018-2029
6.4.4 U.K. Pharmaceutical CDMO Services Market Size, 2018-2029
6.4.5 Italy Pharmaceutical CDMO Services Market Size, 2018-2029
6.4.6 Russia Pharmaceutical CDMO Services Market Size, 2018-2029
6.4.7 Nordic Countries Pharmaceutical CDMO Services Market Size, 2018-2029
6.4.8 Benelux Pharmaceutical CDMO Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pharmaceutical CDMO Services Revenue, 2018-2029
6.5.2 China Pharmaceutical CDMO Services Market Size, 2018-2029
6.5.3 Japan Pharmaceutical CDMO Services Market Size, 2018-2029
6.5.4 South Korea Pharmaceutical CDMO Services Market Size, 2018-2029
6.5.5 Southeast Asia Pharmaceutical CDMO Services Market Size, 2018-2029
6.5.6 India Pharmaceutical CDMO Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pharmaceutical CDMO Services Revenue, 2018-2029
6.6.2 Brazil Pharmaceutical CDMO Services Market Size, 2018-2029
6.6.3 Argentina Pharmaceutical CDMO Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue, 2018-2029
6.7.2 Turkey Pharmaceutical CDMO Services Market Size, 2018-2029
6.7.3 Israel Pharmaceutical CDMO Services Market Size, 2018-2029
6.7.4 Saudi Arabia Pharmaceutical CDMO Services Market Size, 2018-2029
6.7.5 UAE Pharmaceutical CDMO Services Market Size, 2018-2029
7 Pharmaceutical CDMO Services Companies Profiles
7.1 Recipharm AB
7.1.1 Recipharm AB Company Summary
7.1.2 Recipharm AB Business Overview
7.1.3 Recipharm AB Pharmaceutical CDMO Services Major Product Offerings
7.1.4 Recipharm AB Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.1.5 Recipharm AB Key News & Latest Developments
7.2 AMRI Global
7.2.1 AMRI Global Company Summary
7.2.2 AMRI Global Business Overview
7.2.3 AMRI Global Pharmaceutical CDMO Services Major Product Offerings
7.2.4 AMRI Global Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.2.5 AMRI Global Key News & Latest Developments
7.3 Patheon N.V.
7.3.1 Patheon N.V. Company Summary
7.3.2 Patheon N.V. Business Overview
7.3.3 Patheon N.V. Pharmaceutical CDMO Services Major Product Offerings
7.3.4 Patheon N.V. Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.3.5 Patheon N.V. Key News & Latest Developments
7.4 Aenova Group
7.4.1 Aenova Group Company Summary
7.4.2 Aenova Group Business Overview
7.4.3 Aenova Group Pharmaceutical CDMO Services Major Product Offerings
7.4.4 Aenova Group Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.4.5 Aenova Group Key News & Latest Developments
7.5 Catalent, Inc.
7.5.1 Catalent, Inc. Company Summary
7.5.2 Catalent, Inc. Business Overview
7.5.3 Catalent, Inc. Pharmaceutical CDMO Services Major Product Offerings
7.5.4 Catalent, Inc. Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.5.5 Catalent, Inc. Key News & Latest Developments
7.6 Amatsigroup
7.6.1 Amatsigroup Company Summary
7.6.2 Amatsigroup Business Overview
7.6.3 Amatsigroup Pharmaceutical CDMO Services Major Product Offerings
7.6.4 Amatsigroup Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.6.5 Amatsigroup Key News & Latest Developments
7.7 WuXi AppTec Group
7.7.1 WuXi AppTec Group Company Summary
7.7.2 WuXi AppTec Group Business Overview
7.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Major Product Offerings
7.7.4 WuXi AppTec Group Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.7.5 WuXi AppTec Group Key News & Latest Developments
7.8 Strides Pharma Science Limited
7.8.1 Strides Pharma Science Limited Company Summary
7.8.2 Strides Pharma Science Limited Business Overview
7.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Major Product Offerings
7.8.4 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.8.5 Strides Pharma Science Limited Key News & Latest Developments
7.9 Piramal Pharma Solutions
7.9.1 Piramal Pharma Solutions Company Summary
7.9.2 Piramal Pharma Solutions Business Overview
7.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Major Product Offerings
7.9.4 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.9.5 Piramal Pharma Solutions Key News & Latest Developments
7.10 Siegfried Ltd
7.10.1 Siegfried Ltd Company Summary
7.10.2 Siegfried Ltd Business Overview
7.10.3 Siegfried Ltd Pharmaceutical CDMO Services Major Product Offerings
7.10.4 Siegfried Ltd Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.10.5 Siegfried Ltd Key News & Latest Developments
7.11 Fareva Group
7.11.1 Fareva Group Company Summary
7.11.2 Fareva Group Business Overview
7.11.3 Fareva Group Pharmaceutical CDMO Services Major Product Offerings
7.11.4 Fareva Group Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.11.5 Fareva Group Key News & Latest Developments
7.12 FAMAR Health Care Services
7.12.1 FAMAR Health Care Services Company Summary
7.12.2 FAMAR Health Care Services Business Overview
7.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Major Product Offerings
7.12.4 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.12.5 FAMAR Health Care Services Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pharmaceutical CDMO Services Market Opportunities & Trends in Global Market
Table 2. Pharmaceutical CDMO Services Market Drivers in Global Market
Table 3. Pharmaceutical CDMO Services Market Restraints in Global Market
Table 4. Key Players of Pharmaceutical CDMO Services in Global Market
Table 5. Top Pharmaceutical CDMO Services Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pharmaceutical CDMO Services Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pharmaceutical CDMO Services Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pharmaceutical CDMO Services Product Type
Table 9. List of Global Tier 1 Pharmaceutical CDMO Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceutical CDMO Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pharmaceutical CDMO Services Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pharmaceutical CDMO Services Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pharmaceutical CDMO Services Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Pharmaceutical CDMO Services Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pharmaceutical CDMO Services Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pharmaceutical CDMO Services Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Pharmaceutical CDMO Services Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pharmaceutical CDMO Services Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pharmaceutical CDMO Services Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pharmaceutical CDMO Services Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pharmaceutical CDMO Services Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pharmaceutical CDMO Services Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue, (US$, Mn), 2024-2029
Table 30. Recipharm AB Company Summary
Table 31. Recipharm AB Pharmaceutical CDMO Services Product Offerings
Table 32. Recipharm AB Pharmaceutical CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 33. Recipharm AB Key News & Latest Developments
Table 34. AMRI Global Company Summary
Table 35. AMRI Global Pharmaceutical CDMO Services Product Offerings
Table 36. AMRI Global Pharmaceutical CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 37. AMRI Global Key News & Latest Developments
Table 38. Patheon N.V. Company Summary
Table 39. Patheon N.V. Pharmaceutical CDMO Services Product Offerings
Table 40. Patheon N.V. Pharmaceutical CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 41. Patheon N.V. Key News & Latest Developments
Table 42. Aenova Group Company Summary
Table 43. Aenova Group Pharmaceutical CDMO Services Product Offerings
Table 44. Aenova Group Pharmaceutical CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 45. Aenova Group Key News & Latest Developments
Table 46. Catalent, Inc. Company Summary
Table 47. Catalent, Inc. Pharmaceutical CDMO Services Product Offerings
Table 48. Catalent, Inc. Pharmaceutical CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 49. Catalent, Inc. Key News & Latest Developments
Table 50. Amatsigroup Company Summary
Table 51. Amatsigroup Pharmaceutical CDMO Services Product Offerings
Table 52. Amatsigroup Pharmaceutical CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 53. Amatsigroup Key News & Latest Developments
Table 54. WuXi AppTec Group Company Summary
Table 55. WuXi AppTec Group Pharmaceutical CDMO Services Product Offerings
Table 56. WuXi AppTec Group Pharmaceutical CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 57. WuXi AppTec Group Key News & Latest Developments
Table 58. Strides Pharma Science Limited Company Summary
Table 59. Strides Pharma Science Limited Pharmaceutical CDMO Services Product Offerings
Table 60. Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 61. Strides Pharma Science Limited Key News & Latest Developments
Table 62. Piramal Pharma Solutions Company Summary
Table 63. Piramal Pharma Solutions Pharmaceutical CDMO Services Product Offerings
Table 64. Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 65. Piramal Pharma Solutions Key News & Latest Developments
Table 66. Siegfried Ltd Company Summary
Table 67. Siegfried Ltd Pharmaceutical CDMO Services Product Offerings
Table 68. Siegfried Ltd Pharmaceutical CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 69. Siegfried Ltd Key News & Latest Developments
Table 70. Fareva Group Company Summary
Table 71. Fareva Group Pharmaceutical CDMO Services Product Offerings
Table 72. Fareva Group Pharmaceutical CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 73. Fareva Group Key News & Latest Developments
Table 74. FAMAR Health Care Services Company Summary
Table 75. FAMAR Health Care Services Pharmaceutical CDMO Services Product Offerings
Table 76. FAMAR Health Care Services Pharmaceutical CDMO Services Revenue (US$, Mn) & (2018-2023)
Table 77. FAMAR Health Care Services Key News & Latest Developments
List of Figures
Figure 1. Pharmaceutical CDMO Services Segment by Type in 2022
Figure 2. Pharmaceutical CDMO Services Segment by Application in 2022
Figure 3. Global Pharmaceutical CDMO Services Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pharmaceutical CDMO Services Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pharmaceutical CDMO Services Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceutical CDMO Services Revenue in 2022
Figure 8. By Type - Global Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pharmaceutical CDMO Services Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pharmaceutical CDMO Services Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
Figure 16. US Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
Figure 20. Germany Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 21. France Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
Figure 28. China Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 32. India Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
Figure 34. Brazil Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
Figure 37. Turkey Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pharmaceutical CDMO Services Revenue, (US$, Mn), 2018-2029
Figure 41. Recipharm AB Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AMRI Global Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Patheon N.V. Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Aenova Group Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Catalent, Inc. Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amatsigroup Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. WuXi AppTec Group Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Siegfried Ltd Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Fareva Group Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. FAMAR Health Care Services Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
